Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levocetirizine in Perennial Allergic Rhinitis
NCT00521131Phase 4Completed
- Sponsor
- UCB
- Start
- Sep 2002
- Primary completion
- May 2003
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial in perennial allergic rhinitis (PAR) comparing Levocetirizine with Placebo (2 arms). Primary endpoint: Number of comfortable days at 30 days. Started Sep 2002; status: completed.
02
Drugs
levocetirizine
03
Conditions
perennial allergic rhinitis (PAR)
Beyond the preview
Go deeper on NCT00521131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00521131.